These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 4555641)

  • 1. Continued surveillance of Serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):982-5. PubMed ID: 4555641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing.
    Traub WH; Raymond EA
    Appl Microbiol; 1971 Dec; 22(6):1058-63. PubMed ID: 4944804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin sensitivity.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):226-31. PubMed ID: 4552885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriocin (Marcescin) typing of clinical isolates of Serratia marcescens.
    Traub WH; Raymond EA; Startsman TS
    Appl Microbiol; 1971 May; 21(5):837-40. PubMed ID: 4930037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):218-25. PubMed ID: 4552884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Serratia outbreaks in hospital.
    Farmer JJ; Davis BR; Hickman FW; Presley DB; Bodey GP; Negut M; Bobo RA
    Lancet; 1976 Aug; 2(7983):455-9. PubMed ID: 73753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of two methods for bacteriocin typing of Serratia marcescens.
    Lai PS; Ngeow YF; Puthucheary SD; Wang CW
    J Clin Microbiol; 1983 Jan; 17(1):1-6. PubMed ID: 6338029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of MALDI-TOF mass spectrometry to detect nosocomial outbreaks of Serratia marcescens and Citrobacter freundii.
    Rödel J; Mellmann A; Stein C; Alexi M; Kipp F; Edel B; Dawczynski K; Brandt C; Seidel L; Pfister W; Löffler B; Straube E
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):581-591. PubMed ID: 30680577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial outbreak of nitrate-negative Serratia marcescens infections.
    Geiseler PJ; Harris B; Andersen BR
    J Clin Microbiol; 1982 Apr; 15(4):728-30. PubMed ID: 7040469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriocin typing of Serratia marcescens isolates of known serotype-group.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):979-81. PubMed ID: 4555640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using pulsed-field gel electrophoresis in the molecular investigation of an outbreak of Serratia marcescens infection in an intensive care unit.
    Alfizah H; Nordiah AJ; Rozaidi WS
    Singapore Med J; 2004 May; 45(5):214-8. PubMed ID: 15143356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriocin (marcescin) typing of clinically isolated Serratia marcescens.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):33-43. PubMed ID: 7015560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An epidemiological study of Serratia marcescens infections by bacteriocin typing.
    Nasu M; Goto J; Goto I
    Microbiol Immunol; 1982; 26(9):795-801. PubMed ID: 6759881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of ad-hoc molecular typing for infection control measures in a multi-cluster, multi-phenotypic Serratia marcescens outbreak in a neonatal intensive care unit.
    Toorop MMA; Hoogendijk IV; Dogterom-Ballering HCM; Boers SA; Kraakman MEM; van Prehn J; Wessels E; Bekker V; Veldkamp KE
    J Hosp Infect; 2024 Aug; 150():26-33. PubMed ID: 38782059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of three nosocomial outbreaks of Serratia marcescens in an intensive care unit in Sfax-Tunisia].
    Ktari S; Mahjoubi F; Mnif B; Kallel H; Bouaziz M; Hammami A
    Tunis Med; 2010 Jul; 88(7):501-6. PubMed ID: 20582888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological studies of Serratia marcescens infections by bacteriocin (marcescin) typing.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):45-52. PubMed ID: 7015561
    [No Abstract]   [Full Text] [Related]  

  • 17. Bacteriocin typing and biotyping of clinical isolates of Serratia marcescens.
    Traub WH
    Zentralbl Bakteriol; 1991 Oct; 275(4):474-86. PubMed ID: 1755921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial Serratia marcescens individualized by five typing methods in a regional hospital.
    Larose P; Picard B; Thibault M; Grimont F; Goullet P
    J Hosp Infect; 1990 Feb; 15(2):167-72. PubMed ID: 1969439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of pyrolysis mass spectrometry to investigate nosocomial outbreaks caused by Serratia marcescens.
    Nagy E; Koczián Z; Prágai Z; Sisson PR; Freeman R
    Acta Microbiol Immunol Hung; 2000; 47(4):433-43. PubMed ID: 11056763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serratia cross-infection in an intensive therapy unit.
    Mutton KJ; Brady LM; Harkness JL
    J Hosp Infect; 1981 Mar; 2(1):85-91. PubMed ID: 6176629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.